Neostigmine methylsulfate
- Product NDC
- 70700-172
- 11-digit product format
- 707000172
- Labeler code
- 70700
- Product ID
- 70700-172_8649cf31-5ecf-2048-5bf0-1b6e84f190f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Xiromed LLC
- Application
- ANDA212968
- Marketing category
- ANDA
- Marketing start
- 2020-09-09
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neostigmine methylsulfate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NEOSTIGMINE METHYLSULFATE | 1 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 98IMH7M386 |
| Rxcui | 311935, 311936 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 6c2b16d0-96e9-444e-98c5-9883cd6eb72d | Product name | 2 | 20230316 |
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| ad279e69-d021-f6bd-1150-2b55f23832d5 | Product name | 9 | 20211014 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70700-172-22 | ML - Milliliter | 70700-172 | b5c2a670-6cfd-4ec0-8e25-7976385fe9f3 | 1 | 2020-09-14 |
| 70700-172-23 | ML - Milliliter | 70700-172 | b51daa78-89d0-4d71-95ac-fabba2cf872b | 1 | 2020-09-14 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | PSN | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | PSN | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | SCD | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SCD | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | SY | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SY | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | PSN | 3857462f-2d3c-bada-e063-6294a90a7438 | 3 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SCD | 3857462f-2d3c-bada-e063-6294a90a7438 | 3 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SY | 3857462f-2d3c-bada-e063-6294a90a7438 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70700-172-22 | 70700017222 | 1 VIAL, MULTI-DOSE in 1 CARTON (70700-172-22) / 10 mL in 1 VIAL, MULTI-DOSE | 2020-09-09 | 0000-00-00 | No | No | Current |
| 70700-172-23 | 70700017223 | 10 VIAL, MULTI-DOSE in 1 CARTON (70700-172-23) / 10 mL in 1 VIAL, MULTI-DOSE | 2020-09-09 | 0000-00-00 | No | No | Current |